FDMT stock spikes as wet AMD therapy cuts Eylea burden (NASDAQ:FDMT)
Shidlovski Clinical-stage biotech 4D Molecular (NASDAQ:FDMT) gained on Monday after the company announced data indicating that its gene therapy candidate ...
Shidlovski Clinical-stage biotech 4D Molecular (NASDAQ:FDMT) gained on Monday after the company announced data indicating that its gene therapy candidate ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.